Pharmaceutical companies will need to engage meaningfully with a broader stakeholder set in India, beyond just physicians, amid the growing influence of these groups in prescription decisions in the country. This at least is the major finding of a survey by management consultancy Bain & Company in collaboration with the Confederation of Indian Industry (CII).
While almost 80% of physicians covered in the Indian survey indicated that they find it challenging to keep pace with the breadth and the evolution of diseases and treatment protocols in view of the burden of infections and “tsunami” of non-communicable diseases, over 40% reported that drug formularies and insurance restrictions influence their
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?